额部纤维性脱发的药物治疗:综述与临床路径
该综述检索PubMed中270条额部纤维性脱发(FFA)文献,仅纳入报告治疗方案与结局的研究,多为病例报告和回顾性队列研究。病灶内激素和5α-还原酶抑制剂是最常用且阳性应答最多的治疗(分别为88%,181/204和88%,158/180),口服泼尼松仅暂时延缓快速脱发。作者提出FFA自然病程多变,早期干预活动性疾病可能改变病程。
要点
- 病灶内激素和5α-还原酶抑制剂阳性应答率均为88%,是最常用治疗。
- 口服泼尼松少用,仅暂时延缓快速脱发。
- 缺乏安慰剂对照和统一结局指标,证据等级有限。
核心结论
- FFA自然病程多变,前额发际线后退可能无论治疗与否都趋于稳定。
- 对活动性疾病鼓励早期干预,因脱发 presumed permanent 且治疗可能改变病程。
研究设计与样本
- 文献综述:PubMed检索「frontal fibrosing alopecia」返回270条,仅纳入报告治疗方案与结局的研究。
- 纳入研究多为病例报告和回顾性队列研究,以报告能否减缓或阻止脱发评估应答。
主要发现
- 病灶内激素阳性应答88%(181/204),5α-还原酶抑制剂阳性应答88%(158/180)。
- 口服泼尼松少用,仅暂时延缓快速脱发。
- 其他评估疗法包括外用激素、抗生素、吡格列酮、系统性维A酸和毛发移植。
关键数值与推荐
- 病灶内激素:88%(181/204)报告减缓或阻止脱发。
- 5α-还原酶抑制剂:88%(158/180)报告减缓或阻止脱发。
临床怎么用
- 活动性FFA可优先考虑病灶内激素或5α-还原酶抑制剂。
- 口服泼尼松不作为常规,仅可能暂时延缓快速脱发。
- 早期干预活动性疾病,因脱发 presumed permanent。
局限性
- 缺乏安慰剂对照研究。
- 缺乏统一结局指标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines for the treatment of frontal fibrosing alopecia (FFA) are limited, and the literature on treatment modalities consists mostly of case reports and cohort studies. OBJECTIVES: In this review, we sought to assess the response of medical therapy for FFA and propose a clinical approach to management. METHODS: A literature search for "frontal fibrosing alopecia" on PubMed returned 270 items. In this review, only studies with treatment regimens and reported outcomes were considered. The majority of studies found were case reports and retrospective cohort studies. Response to therapy was assessed by reported ability to slow or arrest hair loss. RESULTS: Intralesional steroids and 5α-reductase inhibitors were the most commonly used therapies with the most positive treatment responses (88%, 181/204 for intralesional steroids and 88%, 158/180 for 5α-reductase inhibitors). Oral prednisone was seldom used and only temporarily delayed rapid hair loss. Other therapies evaluated included topical steroids, antibiotics, pioglitazone, systemic retinoids, and hair transplantation. LIMITATIONS: Lack of placebo control studies and uniform outcome measures. CONCLUSION: The natural course of FFA is variable. Recession of the frontal hairline might stabilize regardless of treatment. However, early intervention is encouraged in active disease because hair loss is presumed permanent and treatment could modify the disease course.
引用
- Ho A, Shapiro J. Medical therapy for frontal fibrosing alopecia: A review and clinical approach. J Am Acad Dermatol. 2019. PMID: 30953702. doi:10.1016/j.jaad.2019.03.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。